Hypervirulent Klebsiella pneumoniae ST23 producing OXA-48 in Switzerland-Reference-Cited by-同舟云学术

Hypervirulent Klebsiella pneumoniae ST23 producing OXA-48 in Switzerland

Published:2021-12 Issue:6 Volume:58 Page:106457
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Blanc Dominique S.,Poirel Laurent^ORCID,Van Singer Mathias,Greub Gilbert,Nordmann Patrice

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference5 articles.

1. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed;Shon;Virulence,2013

2. Genomic definition of hypervirulent and multidrug-resistant Klebsiella pneumoniae clonal groups;Bialek-Davenet;Emerg Infect Dis,2014

3. Risk assessment: emergence of hypervirulent Klebsiella pneumoniae ST23 carrying carbapenemase genes in EU/EEA countries,2021

4. NitroSpeed-carba NP test for rapid detection and differentiation between different classes of carbapenemases in Enterobacterales;Nordmann;J Clin Microbiol,2020

5. Detection of multiple hypervirulent Klebsiella pneumoniae strains in a New York city hospital through screening of virulence genes;Parrott;Clin Microbiol Infect,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular characteristics and pathogenic mechanisms of KPC-3 producing hypervirulent carbapenem-resistant Klebsiella pneumoniae (ST23-K1);Frontiers in Cellular and Infection Microbiology;2024-08-15

2. Emergence of Carbapenemase-Producing Hypervirulent Klebsiella pneumoniae in Switzerland;Antimicrobial Agents and Chemotherapy;2023-02-28

3. MDR carbapenemase-producing Klebsiella pneumoniae of the hypervirulence-associated ST23 clone in Poland, 2009–19;Journal of Antimicrobial Chemotherapy;2022-09-30

4. Global spread and evolutionary convergence of multidrug-resistant and hypervirulent Klebsiella pneumoniae high-risk clones;Pathogens and Global Health;2022-09-11

5. OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline;Antimicrobial Agents and Chemotherapy;2022-08-16